OTC Perspectives Magazine Names 'The Top OTC/Healthcare Marketers of the Year'
...of the Year are... (listed alphabetically) Afsha Abid Senior Brand Manager, Excedrin Novartis Innovation & voltaren Consumer Health Marylou Chief Operating Officer, Scerene Arnett Co-Founder ...Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
...d in 2008. Voltaren(R) Gel : Net sales of voltaren Gel were $12.3 million for the three months ended March 31, 2009. voltaren Gel was launched in March 2008. Responding to marketplace demand, voltaren Gel 3 & 5 Packs became available in April 2009...Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
...58.0 million compared with $52.4 million in the same period in 2007. voltaren (R) GEL: Net sales of voltaren GEL were $23.8 million for the year ended December 31, 2008. Generic...Voltaren Linked to Heart Attack
... Researchers have found that although the drug voltaren is commonly used for treating aches and sporting strain, users could be at serious risk of heart attack.// Voltaren’s active ingredient, dicolfenac...FDA causes unnecessary scare about common painkillers
...high doses of Advil (800 mg three times a day) and voltaren (75 mg twice daily) were associated with rates of ...bitors to other NSAIDs found similar results ?that voltaren was estimated to increase vascular risk by about 7...ller of choice," said Furberg. "On the other hand, voltaren carries the same risk as the harmful COX-2 inhibit...Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
... for Lidoderm and strong growth in sales of Opana, voltaren Gel and Supprelin LA," said Dave Holveck, presiden...$26.9 million for the same period in 2008. voltaren ((R)) Gel: In April 2009, we launched the Go A...t co-pays for therapeutic doses of 3 to 5 tubes of voltaren Gel. The program has been well received by patien...